SCHEMBL4846819

SCHEMBL4846819

COc1ccc2c(c1)/C(=C/C(=O)c1ccc(NC(=O)c3ccc(C(F)(F)F)cc3)cc1)NC(C)(C)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 3/20 0.46
ABCG2 Q9UNQ0 2/20 0.43
PLG P00747 1/20 0.43
PLAU P00749 1/20 0.43
PLAT P00750 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
TP53 P04637 2/20 0.41
ALOX15 P16050 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
RXFP1 Q9HBX9 2/20 0.41
PTPN1 P18031 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP1A1 P04798 2/20 0.41
CYP1B1 Q16678 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4846828 1.00 TRPV1 (0.46) TRPV1ABCG2PLGPLAUPLAT
SCHEMBL4845841 0.95 HDAC3 (0.42) TRPV1ABCG2PLGPLAUPLAT
SCHEMBL4840584 0.93 NPC1 (0.51) TRPV1NPC1RAB9A
SCHEMBL4840565 0.93 NPC1 (0.51) TRPV1NPC1RAB9A
SCHEMBL4839109 0.93 RAB9A (0.49) PLAUKDM4EALDH1A1MAPTHPGD
SCHEMBL4839102 0.93 RAB9A (0.49) PLAUKDM4EALDH1A1MAPTHPGD
SCHEMBL4841836 0.93 PLG (0.50) PLGPLAUPLATKDM4EMAPT
SCHEMBL4841846 0.93 PLG (0.50) PLGPLAUPLATKDM4EMAPT
SCHEMBL4844545 0.92 NPC1 (0.48) ABCG2KDM4EALDH1A1MAPTHPGD
SCHEMBL4844535 0.92 NPC1 (0.48) ABCG2KDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 TRPV1 1672/4885ABCG2 4483/4885PLG 1317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.